Skip to content
10-Q

Quarterly Report

Organon & Co. OGN

0001821825-25-000023

← back to feed
Filed
May 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q1 2025 · Mar 31, 2025 $8.94B
Long Term Debt Q1 2025 · Dec 31, 2024 $8.86B
Cash And Equivalents Q1 2025 · Mar 31, 2025 $547M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $675M
Current Liabilities Q1 2025 · Mar 31, 2025 $2.62B
Current Liabilities Q1 2025 · Dec 31, 2024 $2.72B
Total Liabilities Q1 2025 · Mar 31, 2025 $12.61B
Total Liabilities Q1 2025 · Dec 31, 2024 $12.63B
Current Assets Q1 2025 · Mar 31, 2025 $4.37B
Current Assets Q1 2025 · Dec 31, 2024 $4.35B
Total Assets Q1 2025 · Mar 31, 2025 $13.16B
Total Assets Q1 2025 · Dec 31, 2024 $13.1B
Shares Diluted Q1 2025 · Mar 31, 2024 258.36M sh
Dividends Paid Q1 2025 · Mar 31, 2024 $70M
Capex Q1 2025 · Mar 31, 2024 $46M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $76M
Stockholders Equity Q1 2025 · Mar 31, 2024 $48M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$70M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.78
Eps Basic Q1 2025 · Mar 31, 2024 $0.78
Sga Expense Q1 2025 · Mar 31, 2024 $431M
Net Income Q1 2025 · Mar 31, 2024 $201M
Gross Profit Q1 2025 · Mar 31, 2024 $957M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $665M
Revenue Q1 2025 · Mar 31, 2024 $1.62B